DALLAS, August 29, 2014 /PRNewswire/ --
Launched June 2014, the "Stem Cell Research Products - Opportunities, Tools, and Technologies" market intelligence report supplies research supply companies with the real-time data necessary to make effective product development decisions, sell effectively to scientists, and take market share from the competition. Full-year 2013 analysis determines the size of the stem cell research products market to be $3.22 billion, and the stem cell therapies market to be $3.31 billion, for a total of $6.53 billion. In addition, both markets are growing with double-digit growth. Producing stem cell research products thus represents a massive profit opportunity for research supply companies. The research is now available with ReportsnReports.com at http://www.reportsnreports.com/reports/10597-stem-cell-research-products-opportunities-tools-technologies.html .
This 2014 stem cell research products market report is unique in the breadth and depth of input sources that were used to identify industry trends, including: Stem Cell Patent Databases, Stem Cell Publication Databases, Stem Cell Grant Funding Databases, Product Launch Announcements, Press Releases, International Surveys, and more. Specifically, the following sources were utilized:
Stem Cell Patent Databases (USPTO, European Patent Office, World Intellectual Property Organization, State Intellectual Property Office, and Other International Intellectual Property Offices)
Stem Cell Publication Databases (PubMed, Highwire Press, Google Scholar, Mendeley Crowdsourced Database, ScienceDirect)
Stem Cell Grant Funding Databases (NIH database, NSF Find Funding, Grants.gov, Pivot, Grant Forward, The Foundation Directory, and Private Donor Statements)
Stem Cell Clinical Trial Databases (ClinicalTrials.gov and the International Clinical Trials Registry Platform)
Stem Cell Product Launch Announcements (Press Releases, Trade Journals, Google News, Online Ads)
International Surveys (End-user Survey of 289 Stem Cell Researchers) and much more.
A distinctive feature of this report is an end-user survey of 289 researchers worldwide that identify as having stem cells as their core research focus (97 U.S. / 173 International / 19 Undefined). These survey findings reveal stem cell researcher needs, technical preferences, key factors influencing buying decisions, and more. In reference to the "Scientist Survey" contained within the report, the Head of Project Management of the report's publisher said, "The report provides insights into the minds of 289 stem cell researchers worldwide, revealing their needs, technical preferences, and current purchasing decisions. You can use it to create high-demand products that will have researchers pursuing your products over the competition." Order a copy of this report at http://www.reportsnreports.com/Purchase.aspx?name=10597 .
This 2014 report provides detailed information on both basic and applied stem cell research and research applications and includes an updated list of global stem cell research centers by region. Furthermore, it is crucial for stem cell companies to understand the funding environment that supports stem cell research. Currently, the U.S. federal government is an important, although not dominant, source of funding for stem cell research. The reason is that U.S. states are spending almost as much as the federal government on stem cell research and are actually spending more than the federal government on human embryonic stem cell (hESC) research. Private sources also contribute a huge amount of funding, with analysis of recent large gifts summing to over $1.7 billion.
The two most active areas of stem cell research are mesenchymal stem cells, at 24.8% of all stem cell research, and hematopoietic stem cells, at 24.1% - thus accounting for nearly half of all stem cell research over a trailing twelve-month period. When this analysis was last conducted using data from full-year 2012 (Jan 1, 2012 - Dec 31, 2012), hematopoietic stem cell research led mesenchymal stem cell research, but that relationship has since switched, revealing an interesting preference toward mesenchymal stem cell research among the scientific community.
Also of interest is that for the trailing-twelve months, induced pluripotent stem cell research activity represented 8.9% of global stem cell research activity. When this analysis was last conducted using full-year 2012 data (Jan 1, 2012 - Dec 31, 2012), induced pluripotent stem cell research activity represented only 4.0% of global research activity, which means that a substantial year-over-year shift has occurred. This report explores why this trend has developed and how it will continue to evolve in the coming decade. Not surprisingly, trend analysis reveals rapid increases in stem cell research activity over the past five years, specifically a scientific publication rate increase of 9.9% per year.
Thermo Fisher Scientific (Recently Merged with Life Technologies / Includes Invitrogen Brand) and BD Biosciences have been discussed for their diverse stem cell product lines in this 2014 report on Stem Cell Research Products - Opportunities, Tools, and Technologies.
Complete 2013-14 Induced Pluripotent Stem Cell (iPSC) Industry Report is another 2014 research of 127 pages that says the burgeoning iPSC product market lures major industry competitors with double-digit growth and massive change in 2013. The number of iPSC research products sold worldwide has been growing at an annual rate of 14.7% for the past five years. In addition, 22% of all stem cell researchers now self-report as having used induced pluripotent stem cells within a research project. It is clear that iPSCs are a vital research trend within the scientific community. A distinctive feature of this report is an end-user survey of 274 researchers (131 U.S. / 143 International) that identify as having induced pluripotent stem cells as their core research focus. These survey findings reveal iPSC researcher needs, technical preferences, key factors influencing buying decisions, and more. They can be used to make effective product development decisions, create targeted marketing messages, and produce higher prospect-to-client conversion rates. Read more at http://www.reportsnreports.com/reports/206575-complete-2012-13-induced-pluripotent-stem-cell-industry-report.html .
Explore more reports on biotechnology market and others by BioInformant Worldwide, LLC at http://www.reportsnreports.com/publisher/bioinformant-worldwide-llc/ .
ReportsnReports.com is an online market research reports library of 450,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers.
Connect With Us on:
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252